Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
David S
DS
Whitcomb
D000208:Acute Disease / Q000628:therapy; D002545:Brain Ischemia / Q000188:drug therapy*; D002985:Clinical Protocols / Q000592:standards*; D003627:Data Interpretation, Statistical; D004632:Emergency Medical Services / Q000379:methods / Q000592:standards / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000592:standards / Q000627:therapeutic use; D005568:Forms and Records Control / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000379:methods / Q000592:standards; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000592:standards* / Q000706:statistics & numerical data; D010959:Tissue Plasminogen Activator / Q000592:standards* / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator